Nrf2 Activator Compounds for Oxidative Stress Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective Nrf2 activators to treat diseases caused by oxidative stress, such as neurodegenerative diseases, inflammation, autoimmune diseases, and hemoglobinopathies, as current treatments are inadequate in addressing these conditions.
Innovation Solution
The development of specific compounds, represented by Formula I and its variations, which act as Nrf2 activators by inducing the production of proteins that combat oxidative stress, thereby treating diseases like neurodegenerative disorders, inflammation, and hemoglobinopathies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for oxidative stress-related diseases, then existing therapeutic options are available, but they are inadequate in addressing the underlying oxidative stress mechanisms
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of Nrf2 activator compounds through systematic variation of substituents (R1, R2, R3a, R3b, R4, R5, R6 groups) to optimize biological activity. This involves changing molecular parameters such as lipophilicity, steric bulk, and electronic properties to enhance Nrf2 pathway activation while improving therapeutic effectiveness for oxidative stress-related diseases
2Adaptability or versatility
If Nrf2 activator compounds are developed to treat multiple disease types, then versatility in treating oxidative stress-related diseases is improved, but the complexity of compound design and development increases
Solution Approach 1:
The patent implements universality by designing a core molecular scaffold that can activate Nrf2 pathway across multiple disease contexts including neurodegenerative diseases, inflammatory conditions, and hemoglobinopathies. The compound structure is designed to perform multiple therapeutic functions through a single molecular entity, enabling broad applicability while managing design complexity through a unified structural platform
Solution Approach 2:
The patent applies segmentation by dividing the molecular structure into distinct functional domains (core scaffold, substituent groups R1-R6) that can be independently optimized. This modular approach allows systematic exploration of structure-activity relationships by varying specific segments while maintaining the core Nrf2-activating functionality, thereby managing complexity through structured decomposition
Data Source
AI summary
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.